Rabiei S, Hedayati M, Rashidkhani B, Saadat N, Shakerhossini R (2019) The effects of synbiotic supplementation on body mass index, metabolic and inflammatory biomarkers, and appetite in patients with metabolic syndrome: a triple-blind randomized controlled trial
Both are in Phase 23 clinical development and are not approved for any use
The blog explores the transformative effects of topical peptides in skincare and anti-aging, emphasizing their ability to reduce wrinkles and boost collagen production for youthful skin
Should GLP-1 patches complete clinical development and receive regulatory approval in future, they would undergo health technology assessment by NICE to determine cost-effectiveness and appropriate positioning within NHS treatment pathways
PlexusDx provides an insurance-independent pathway to GLP-1 therapy through licensed 503A compounding pharmacies